Table 5.
NO. | Molecular Subtypes | 5-years survival | 10-years survival | 15-years survival |
---|---|---|---|---|
1 | luminal B | 91% | 76% | 65% |
2 | luminal A | 91% | 79% | 69% |
3 | HER2-enriched | 88% | 76% | 68% |
4 | Triple negative | 84% | 74% | 66% |
The bold values represent the highest values of mean survival probabilities for each molecular subtype (luminal A, ER-positive/or PR-positive/HER2-negative; luminal B, ER-positive/or PR-positive/HER-positive; triple negative, ER-negative/PR-negative/HER-negative; HER2-enriched, ER negative/PR-negative/HER2-positive).